An EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor that interferes with the action of Ca2+-transporting ATPase (EC 3.6.3.8).
Any member of a group of drugs that reversibly inhibit the propagation of signals along nerves. Wide variations in potency, stability, toxicity, water-solubility and duration of action determine the route used for administration, e.g. topical, intravenous, epidural or spinal block.
An amide-type local anaesthetic, levobupivacaine has a longer duration of action and is associated with less vasodilation than racemic bupivacaine, but is approximately 13% less potent (by molarity). It is commonly used as the hydrochloride salt.